Try our beta test site
1392 studies found for:    "Soft tissue sarcoma"
Show Display Options
Rank Status Study
1 Active, not recruiting Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Intervention: Drug: GPX-150 for Injection
2 Recruiting Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall
Condition: Soft Tissue Sarcoma
Intervention: Radiation: Hypofractionated Radiation Therapy
3 Not yet recruiting A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma
Condition: Soft-tissue Sarcoma
Interventions: Drug: Olaparib;   Radiation: Concomitant Radiotherapy
4 Withdrawn Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas
Condition: Soft Tissue Sarcomas
Interventions: Drug: Chemoradiotherapy Temozolomide;   Radiation: Proton therapy;   Procedure: Proton Chemoradiotherapy followed by surgery
5 Completed
Has Results
An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced or Metastatic Soft Tissue Sarcoma (Study E7389-J081-217)
Condition: Soft Tissue Sarcoma
Intervention: Drug: eribulin mesylate
6 Completed
Has Results
Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall
Condition: Soft Tissue Sarcoma
Intervention: Drug: Sorafenib
7 Active, not recruiting A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas
Condition: Soft Tissue Sarcoma
Intervention: Drug: Axitinib
8 Completed Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Intervention: Drug: Ifosfamide
9 Completed Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Intervention: Drug: Sunitinib
10 Completed NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma of the Extremity
Condition: Adult Soft Tissue Sarcoma
Intervention: Device: NBTXR3
11 Recruiting A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall
Condition: Soft Tissue Sarcoma
Interventions: Radiation: proton radiation;   Procedure: surgery (wide local excision; limb preservation surgery)
12 Completed Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)
Condition: Soft Tissue Sarcoma
Intervention: Drug: Vorinostat
13 Active, not recruiting A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Interventions: Drug: Pazopanib;   Drug: Doxorubicin
14 Withdrawn Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Intervention: Drug: ridaforolimus
15 Completed Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide
Condition: Soft Tissue Sarcoma
Intervention:
16 Terminated
Has Results
Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Intervention: Drug: Pomalidomide
17 Completed Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study
Condition: Soft Tissue Sarcoma
Intervention:
18 Unknown  Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Intervention: Drug: Sorafenib
19 Unknown  Therapeutic Response of Patients With Soft Tissue Sarcoma According to CHOI Criteria
Condition: Soft Tissue Sarcoma
Intervention:
20 Completed Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Intervention: Drug: TH-302

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.